In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stentys' Shifting Focus: Moving Beyond Bifurcations, Stenting for AMI

Executive Summary

Launched to develop a better stent for treating bifurcated lesions, Stentys discovered its device appears to be effective in treating a larger unmet clinical need: acute myocardial infarction. This strategy shift holds great promise, but the company must convince physicians that its self-expanding stent will succeed where others have failed, and that it is superior to traditional stents from the major cardiovascular players.
Advertisement

Related Content

Stentys' IPO: European Public Markets Opening For Device Companies?
Stentys' IPO: European Public Markets Opening For Device Companies?
Cappella: Can a New Twist On An Old Idea Solve the Bifurcation Challenge?
Cappella: Can a New Twist On An Old Idea Solve the Bifurcation Challenge?
Tryton Medical: Going Against the Flow in Bifurcated Stents
Tryton Medical: Going Against the Flow in Bifurcated Stents
Embolic Protection: Unmet Clinical Need or Unneeded Technology
Minvasys: Tailoring the Stent to Fit the Lesion in Bifurcations
Bifurcation Stenting: The Next Generation
Stents Branch Out and Return to Their Start-Up Roots

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel